| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,323,049 |
| 52
Week Range: |
$0.937 - $1.235 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2008-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
597,139 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2008-11-03 |
4 |
S |
$1.82 |
$9,100 |
D/D |
(5,000) |
209,773 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2008-10-30 |
4 |
S |
$1.60 |
$8,000 |
D/D |
(5,000) |
214,773 |
|
- |
|
| Fulmer Richard |
Director |
– • – |
2008-07-15 |
4 |
A |
$1.44 |
$10,793 |
D/D |
7,500 |
17,500 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2008-06-26 |
4 |
A |
$1.33 |
$41,699 |
D/D |
30,000 |
216,216 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2008-06-26 |
4 |
A |
$1.33 |
$13,398 |
D/D |
10,000 |
406,402 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2008-06-25 |
4 |
A |
$1.48 |
$148 |
D/D |
100 |
186,216 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2008-06-24 |
4 |
A |
$1.43 |
$14,300 |
D/D |
10,000 |
396,402 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2008-06-23 |
4 |
A |
$1.45 |
$29,347 |
D/D |
20,000 |
386,402 |
|
- |
|
| Vida Julius A |
Director |
– • – |
2008-05-23 |
4 |
A |
$1.78 |
$2,134 |
D/D |
1,200 |
11,200 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2008-05-02 |
5 |
GD |
$1.94 |
$23,998 |
D/D |
12,370 |
597,139 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
184,434 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
364,376 |
|
- |
|
| Kumaria Shyam K |
Vice President Finance |
• – – |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
62,404 |
|
- |
|
| Kumaria Shyam K |
Vice President Finance |
• – – |
2007-11-26 |
4 |
A |
$2.75 |
$11,000 |
D/D |
4,000 |
53,404 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2007-11-21 |
4 |
A |
$2.70 |
$27,811 |
D/D |
10,000 |
324,376 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2007-11-21 |
4 |
A |
$2.72 |
$13,600 |
D/D |
5,000 |
166,434 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2007-08-01 |
4 |
A |
$3.58 |
$17,900 |
D/D |
5,000 |
161,316 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2007-08-01 |
4 |
A |
$3.58 |
$17,946 |
D/D |
5,000 |
314,255 |
|
- |
|
| Lenaz Luigi Md |
Chief Scientific Officer |
• – – |
2007-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
156,316 |
|
- |
|
| Kumaria Shyam K |
Vice President Finance |
• – – |
2007-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
49,192 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2007-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
309,255 |
|
- |
|
| Vida Julius A |
Director |
– • – |
2007-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2007-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
|
- |
|
| Fulmer Richard |
Director |
– • – |
2007-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
|
- |
|
658 Records found
|
|
Page 25 of 27 |
|
|
